IDEXX Laboratories Inc. (IDXX): Price and Financial Metrics

IDXX POWR Grades

• Quality is the dimension where IDXX ranks best; there it ranks ahead of 91.95% of US stocks.
• The strongest trend for IDXX is in Value, which has been heading down over the past 178 days.
• IDXX's current lowest rank is in the Momentum metric (where it is better than 13.65% of US stocks).

IDXX Stock Summary

• With a market capitalization of $39,077,332,955, IDEXX LABORATORIES INC has a greater market value than 94.44% of US stocks.
• IDEXX LABORATORIES INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 91.99% of US listed stocks.
• Price to trailing twelve month operating cash flow for IDXX is currently 71.97, higher than 94.74% of US stocks with positive operating cash flow.
• Stocks that are quantitatively similar to IDXX, based on their financial statements, market capitalization, and price volatility, are UEIC, A, BDX, MASI, and LOGI.
• IDXX's SEC filings can be seen here. And to visit IDEXX LABORATORIES INC's official web site, go to www.idexx.com.

IDXX Valuation Summary

• IDXX's price/earnings ratio is 57.5; this is 154.42% higher than that of the median Healthcare stock.
• IDXX's price/sales ratio has moved up 8.6 over the prior 243 months.

Below are key valuation metrics over time for IDXX.

IDXX Growth Metrics

Its 5 year price growth rate is now at 65.5%.
• Its 2 year net cashflow from operations growth rate is now at 64.77%.
• Its year over year revenue growth rate is now at 14.56%.

IDXX's revenue has moved up $1,197,347,000 over the prior 52 months.

The table below shows IDXX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	3,367.324	542.984	679.089
2022-09-30	3,339.846	579.52	669.653
2022-06-30	3,308.606	577.725	663.95
2022-03-31	3,274.202	745.83	734.553
2021-12-31	3,215.36	755.546	744.845
2021-09-30	3,135.208	764.516	756.864

IDXX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IDXX has a Quality Grade of A, ranking ahead of 96.19% of graded US stocks.
• IDXX's asset turnover comes in at 1.342 -- ranking 14th of 680 Pharmaceutical Products stocks.
• IMGN, RMTI, and MTEX are the stocks whose asset turnover ratios are most correlated with IDXX.

The table below shows IDXX's key quality metrics over time.